The following peer-reviewed publications use CMRtools and its plug-ins.
 
[1] Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron
Haematologica 2006; 91:1388-1391
Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ
[2] Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in Thalassemia Major
Journal of Magnetic Resonance Imaging 2005; 22:229-233
Westwood MA, Wonke B, Maceira AM, Prescott E, Walker JM, Porter JB, Pennell DJ
 
 
[3] A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload
Journal of Magnetic Resonance Imaging 2003: 18:33-39
Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennell DJ
 
 
[4] Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
Blood 2006; 107(9): 3738-3744
Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis EF, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R
 
 
[5] Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
European Heart Journal 2001; 22: 2171-2179
Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker MJ, Pennell DJ
 
 
[6] Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thallasaemia
The International Journal of Cardiovascular Imaging 2005: 21: 531-538
Westwood MA, Firmin DN, Gildo M, Renzo G, Stathis G, Markissia K, Vasili B, Pennell DJ
 
 
[7] Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in Thalassemia
Journal of Magnetic Resonance Imaging 2003; 18:616-620
Westwood MA, Anderson LJ, Firmin DN, Gatehouse PD, Lorenz CH, Wonke B, Pennell DJ
 
 
[8] Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia
The Lancet 2002; 360:516-520
Anderson LJ, Wonke B, Prescott E, Holden S, Wlaker MJ, Pennell DJ
 
[9] Myocardial iron loading in patients with Thalassemia Major on Deferoxamine Chelation
Journal of Cardiovascular Magnetic Resonance 2006; 8;543-547
Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV, Anderson LJ, Walker JM, Pennell DJ
 
 
[10] A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance
Circulation 2007;115;1876-1884;
Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Roughton M, Assomull R, Nair SV, Walker JM and Pennell DJ
[11] Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction
Journal of Cardiovascular Magnetic Resonance 2008; 10:12;
Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Pibiri M, Nair SV, Walker JM,Pennell DJ
 
 
[12] Differentiation of Cardiomyopathies by use of CMR
MAGNETOM Flash 2/2007
O’Hanlon R, Pennell DJ, Schulz-Menger J, Waßmuth R 
 
[13] Effect of ventricle motion on the dynamic behaviour of chorded mitral valves
Journal of Fluids and Structures 24 (2008) 58–74
Watton PN, Luo XY, Yin M, Bernacca GM, Wheatley DJ
[14] Left ventricular function and mass after orthotopic heart transplantation: a comparison of cardiovascular magnetic resonance with echocardiography
The Journal of Heart and Lung Transplantation 2000; 19:5; 444-452;
Bellenger NG, Marcus NJ, Davies C, Yacoub M, Banner NR, Pennell DJ
 
[15] Measurement of Ventricular Volumes and Function: A Comparison of Gated PET and Cardiovascular Magnetic Resonance
The Journal of Nuclear Medicine 2002; 43:6;
Rajappan K, Livieratos L, Camici PG, Pennell DJ
 
[16] The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin,and unobstructed coronary arteries
European Heart Journal 2007
Assomull RG, Lyne JC, Keenan N, Gulati A, Bunce NH,Davies SW, Pennell DJ, Prasad SK
[17] Toward Clinical Risk Assessment in Hypertrophic Cardiomyopathy With Gadolinium Cardiovascular Magnetic Resonance
Journal of the American College of Cardiology 2003; 41:9;
Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ
 
 
[18] A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major
Haematologica 2008; 93:1;
Au WJ, Lam WWM, Chu W, Tam S, Wong WK, Liang R, Ha SY
 
[19] Ventricular Fibrosis Suggested by Cardiovascular Magnetic Resonance in Adults With Repaired Tetralogy of Fallot and Its Relationship to Adverse Markers of Clinical Outcome
Circulation 2006;113:405-413;
Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, Khan M, Ho SY, Pennell DJ, Gatzoulis MA
Selected publications using CMRtools